Limited efficacy of West Nile virus vaccines in large falcons (Falco spp.).

Joke Angenvoort, Dominik Fischer, Christine Fast, Ute Ziegler, Martin Eiden, Jorge Garcia de la Fuente, Michael Lierz, Martin H Groschup

Veterinary research 2014 Apr 07

filter terms:

West Nile virus (WNV) can lead to fatal diseases in raptor species. Unfortunately, there is no vaccine which has been designed specifically for use in breeding stocks of falcons. Therefore the immunogenicity and protective capacity of two commercially available WNV vaccines, both approved for use in horses, were evaluated in large falcons. One vaccine contained adjuvanted inactivated WNV lineage 1 immunogens, while the second represented a canarypox recombinant live virus vector vaccine. The efficacy of different vaccination regimes for these two vaccines was assessed serologically and by challenging the falcons with a WNV strain of homologous lineage 1. Our studies show that the recombinant vaccine conveys a slightly better protection than the inactivated vaccine, but moderate (recombinant vaccine) or weak (inactivated vaccine) side effects were observed at the injection sites. Using the recommended 2-dose regimen, both vaccines elicited only sub-optimal antibody responses and gave only partial protection following WNV challenge. Better results were obtained for both vaccines after a third dose, i.e. alleviation of clinical signs, absence of fatalities and reduction of virus shedding and viraemia. Therefore the consequences of WNV infections in falcons can be clearly alleviated by vaccination, especially if the amended triple administration scheme is used, although side effects at the vaccination site must be accepted.

Citation

Joke Angenvoort, Dominik Fischer, Christine Fast, Ute Ziegler, Martin Eiden, Jorge Garcia de la Fuente, Michael Lierz, Martin H Groschup. Limited efficacy of West Nile virus vaccines in large falcons (Falco spp.). Veterinary research. 2014 Apr 07;45:41